This week we'll discuss a recent trial on mepolizumab - and IL-5 inhibitor - for eosinophilic granulomatosis with polyangiitits. Find the paper here and be sure to follow us on twitter @JBRheum!
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"The Evidence Based Rheumatology Podcast","authorlink":""},"src":"https:\/\/mcdn.podbean.com\/mf\/web\/yfrj8f\/E8_Mepolizumab_for_EGPA_.mp3","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202106\/f4c999-1aa9-b99e-7c0453_800.png"},"title":"E8: Mepolizumab or Placebo for EGPA","link":"javascript:;","id":"item-262737"}]
